BCB Bancorp Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BCB Bancorp, Inc. on July 6, 2017, covering events occurring on June 30, 2017. The filing details the closing of a private placement of equity securities.
Key Financial Metrics
The filing reports the following specific financial data related to the equity transaction:
- Gross Proceeds: $4,260,000 from the closing of the remaining Series D shares.
- Shares Issued: 426 shares of Series D Noncumulative Perpetual Preferred Stock.
- Price Per Share: $10,000.
- Total Offering Size: The complete Series D offering consisted of 954 shares with total gross proceeds of $9,540,000.
- Capital Structure Impact: The 426 shares sold represent 31.74% of the total issued and outstanding Noncumulative Perpetual Preferred Stock (including Series C).
The filing text does not provide clear values for revenue, net profit, operating cash flow, margins, debt levels, or general liquidity metrics beyond the proceeds from this specific transaction.
Material Changes
The primary material change is the increase in the company's capital base through the issuance of preferred stock. The transaction was executed under the exemption from registration provided by SEC Rule 506 of Regulation D.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk factors related to future operations. The document focuses solely on the disclosure of the unregistered sale of equity securities.
Key Facts for Investor Verification
- Verify the total outstanding count of Series C and Series D preferred stock to confirm the 31.74% ownership stake calculation.
- Confirm the use of the $4,260,000 in gross proceeds (e.g., capital strengthening, debt repayment, or general corporate purposes).
- Review the terms of the Series D Noncumulative Perpetual Preferred Stock, specifically dividend rates and redemption features, which are not detailed in this summary.
- Check subsequent filings for the impact of this capital raise on the company's regulatory capital ratios.